Brief: Cannara Biotech Q4 EPS CAD 0.04
Nov 24 (Reuters) - Cannara Biotech Q4 net income CAD 3.3 million. Q4 revenue CAD 28.3 million
Recent news on Cannara Biotech
See all newsBrief: Cannara Biotech - Enters Amended Syndicated Credit Agreement With BMO And Td
Cannara Biotech Q3 revenue tops estimates on expanded distribution
Canada Research Roundup: Cannara Biotech ,Equinox Gold , Winpak
Brief: Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced At C$2.10 Per Common Share
Brief: Cannara Biotech Delivers Q4